CD86 and head and neck squamous cell carcinoma: Taken together, HNSCC-sEVs downregulated M1 marker CD86, but also M2 marker CD163, as well as other immune relevant markers, indicating a mixed phenotype rather than a clear M1 or M2 polarisation of macrophages.